Case Report
Published on 05 Jan 2022
Case Report: Anti-LGI1 Encephalitis Following COVID-19 Vaccination
in Multiple Sclerosis and Neuroimmunology
Frontiers in Immunology
doi 10.3389/fimmu.2021.813487
- 29,654 views
- 48 citations
Type at least 3 characters
1,481 articles
articles
Original Research
Published on 05 Jan 2022
Pregnancy-Related Attack in Neuromyelitis Optica Spectrum Disorder With AQP4-IgG: A Single-Center Study and Meta-Analysis
in Multiple Sclerosis and Neuroimmunology
Frontiers in Immunology
doi 10.3389/fimmu.2021.800666
- 5,270 views
- 12 citations
Original Research
Published on 04 Jan 2022
Dysregulated TP53 Among PTSD Patients Leads to Downregulation of miRNA let-7a and Promotes an Inflammatory Th17 Phenotype
in Multiple Sclerosis and Neuroimmunology
Frontiers in Immunology
doi 10.3389/fimmu.2021.815840
- 4,253 views
- 16 citations
Systematic Review
Published on 24 Dec 2021
Targeting TREM2 for Parkinson’s Disease: Where to Go?
in Multiple Sclerosis and Neuroimmunology
Frontiers in Immunology
doi 10.3389/fimmu.2021.795036
- 10,797 views
- 30 citations
Original Research
Published on 24 Dec 2021
Integrated Lymphopenia Analysis in Younger and Older Patients With Multiple Sclerosis Treated With Cladribine Tablets
in Multiple Sclerosis and Neuroimmunology
Frontiers in Immunology
doi 10.3389/fimmu.2021.763433
- 8,035 views
- 13 citations
Editorial
Published on 24 Dec 2021
Editorial: Immune Response to Cerebral Ischemia: Exploring Mechanisms and Potential Treatment Targets
in Multiple Sclerosis and Neuroimmunology
Frontiers in Immunology
doi 10.3389/fimmu.2021.813836
- 3,186 views
- 1 citation
Case Report
Published on 23 Dec 2021
Case Report: Clinical and Imaging Characteristics of a Patient with Anti-flotillin Autoantibodies: Neuromyelitis Optica or Multiple Sclerosis?
in Multiple Sclerosis and Neuroimmunology
Frontiers in Immunology
doi 10.3389/fimmu.2021.808420
- 3,960 views
- 2 citations
Mini Review
Published on 23 Dec 2021
Encephalitic Arboviruses of Africa: Emergence, Clinical Presentation and Neuropathogenesis
in Multiple Sclerosis and Neuroimmunology
Frontiers in Immunology
doi 10.3389/fimmu.2021.769942
- 8,978 views
- 10 citations
Editorial
Published on 20 Dec 2021
Editorial: Assessing Microglial Function and Identity
in Multiple Sclerosis and Neuroimmunology
Frontiers in Immunology
doi 10.3389/fimmu.2021.824866
- 3,181 views
Original Research
Published on 17 Dec 2021
C3a Receptor Signaling Inhibits Neurodegeneration Induced by Neonatal Hypoxic-Ischemic Brain Injury
in Multiple Sclerosis and Neuroimmunology
Frontiers in Immunology
doi 10.3389/fimmu.2021.768198
- 5,930 views
- 19 citations
Review
Published on 16 Dec 2021
The “Dialogue” Between Central and Peripheral Immunity After Ischemic Stroke: Focus on Spleen
in Multiple Sclerosis and Neuroimmunology
Frontiers in Immunology
doi 10.3389/fimmu.2021.792522
- 12,238 views
- 43 citations
Editorial
Published on 16 Dec 2021
Editorial: A Microbial View of Central Nervous System Disorders: Interplay Between Microorganisms, Neuroinflammation and Behaviour
in Multiple Sclerosis and Neuroimmunology
Frontiers in Immunology
doi 10.3389/fimmu.2021.816227
- 4,256 views
- 2 citations
Original Research
Published on 16 Dec 2021
Treatment With CD52 Antibody Protects Neurons in Experimental Autoimmune Encephalomyelitis Mice During the Recovering Phase
in Multiple Sclerosis and Neuroimmunology
Frontiers in Immunology
doi 10.3389/fimmu.2021.792465
- 5,680 views
- 8 citations
Review
Published on 16 Dec 2021
The Role of Immune Cells in Post-Stroke Angiogenesis and Neuronal Remodeling: The Known and the Unknown
in Multiple Sclerosis and Neuroimmunology
Frontiers in Immunology
doi 10.3389/fimmu.2021.784098
- 21,414 views
- 101 citations
Review
Published on 16 Dec 2021
Innate Receptors Expression by Lung Nociceptors: Impact on COVID-19 and Aging
in Multiple Sclerosis and Neuroimmunology
Frontiers in Immunology
doi 10.3389/fimmu.2021.785355
- 9,444 views
- 7 citations
Original Research
Published on 16 Dec 2021
Soluble Receptor Isoform of IFN-Beta (sIFNAR2) in Multiple Sclerosis Patients and Their Association With the Clinical Response to IFN-Beta Treatment
in Multiple Sclerosis and Neuroimmunology
Frontiers in Immunology
doi 10.3389/fimmu.2021.778204
- 5,532 views
- 8 citations
Original Research
Published on 15 Dec 2021
Altered Plasma Metabolic Profiles in Chinese Patients With Multiple Sclerosis
in Multiple Sclerosis and Neuroimmunology
Frontiers in Immunology
doi 10.3389/fimmu.2021.792711
- 7,176 views
- 17 citations
Original Research
Published on 15 Dec 2021
Clinical and Radiological Characteristics of Children and Adults With First-Attack Myelin Oligodendrocyte Glycoprotein Antibody Disease and Analysis of Risk Factors for Predicting the Severity at Disease Onset in Central China
in Multiple Sclerosis and Neuroimmunology
Frontiers in Immunology
doi 10.3389/fimmu.2021.752557
- 4,068 views
- 12 citations
Original Research
Published on 14 Dec 2021
Treatment With Cladribine Selects IFNγ+IL17+ T Cells in RRMS Patients – An In Vitro Study
in Multiple Sclerosis and Neuroimmunology
Frontiers in Immunology
doi 10.3389/fimmu.2021.743010
- 5,727 views
- 3 citations
Review
Published on 13 Dec 2021
Biological Functions and Regulatory Mechanisms of Hypoxia-Inducible Factor-1α in Ischemic Stroke
in Multiple Sclerosis and Neuroimmunology
Frontiers in Immunology
doi 10.3389/fimmu.2021.801985
- 24,010 views
- 119 citations
Original Research
Published on 09 Dec 2021
Heterogeneity of White Matter Hyperintensities in Cognitively Impaired Patients With Cerebral Small Vessel Disease
in Multiple Sclerosis and Neuroimmunology
Frontiers in Immunology
doi 10.3389/fimmu.2021.803504
- 10,832 views
- 31 citations
Original Research
Published on 08 Dec 2021
Antibodies to Full-Length Agrin Protein in Chinese Patients With Myasthenia Gravis
in Multiple Sclerosis and Neuroimmunology
Frontiers in Immunology
doi 10.3389/fimmu.2021.753247
- 5,794 views
- 8 citations
Original Research
Published on 08 Dec 2021
Long Non-Coding RNA- Associated Competing Endogenous RNA Axes in T-Cells in Multiple Sclerosis
in Multiple Sclerosis and Neuroimmunology
Frontiers in Immunology
doi 10.3389/fimmu.2021.770679
- 4,858 views
- 12 citations
Original Research
Published on 07 Dec 2021
Identification and Clinical Validation of Key Extracellular Proteins as the Potential Biomarkers in Relapsing-Remitting Multiple Sclerosis
in Multiple Sclerosis and Neuroimmunology
Frontiers in Immunology
doi 10.3389/fimmu.2021.753929
- 18,686 views
- 28 citations